106 related articles for article (PubMed ID: 23788013)
1. Cytology use for cervical cancer screening in Portugal: results from the 2005/2006 National Health Survey.
Oliveira M; Peleteiro B; Lunet N
Eur J Public Health; 2014 Apr; 24(2):253-8. PubMed ID: 23788013
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and determinants of cervical cytology use in an urban sample of Portuguese women.
Alves C; Alves L; Lunet N
Eur J Cancer Prev; 2009 Nov; 18(6):482-8. PubMed ID: 19734793
[TBL] [Abstract][Full Text] [Related]
3. Mammography use for breast cancer screening in Portugal: results from the 2005/2006 National Health Survey.
Dourado F; Carreira H; Lunet N
Eur J Public Health; 2013 Jun; 23(3):386-92. PubMed ID: 22874736
[TBL] [Abstract][Full Text] [Related]
4. Cervical cytology use in Portugal: Results from the National Health Survey 2014.
Rukhadze L; Lunet N; Peleteiro B
J Obstet Gynaecol Res; 2019 Jul; 45(7):1286-1295. PubMed ID: 31034140
[TBL] [Abstract][Full Text] [Related]
5. Inequalities in adherence to cervical cancer screening in Portugal.
Nunes MF; Leite AH; Dias SF
Eur J Cancer Prev; 2021 Mar; 30(2):171-177. PubMed ID: 32732693
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and determinants in cytology testing for cervical cancer screening in Spain (2006-14).
Cobo-Cuenca AI; Rodríguez-Borrego MA; Hidalgo-Lópezosa P; Rodríguez-Muñoz PM; Martins M; Carmona-Torres JM
Eur J Public Health; 2018 Jun; 28(3):410-415. PubMed ID: 29444273
[TBL] [Abstract][Full Text] [Related]
7. Mammography Use in Portugal: National Health Survey 2014.
Chkotua S; Peleteiro B
Prev Chronic Dis; 2017 Oct; 14():E100. PubMed ID: 29049019
[TBL] [Abstract][Full Text] [Related]
8. Social disparities in access to breast and cervical cancer screening by women living in Spain.
Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López de Andrés A
Public Health; 2015 Jul; 129(7):881-8. PubMed ID: 25818014
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and determinants of cervical cancer screening with a combination of cytology and human papillomavirus testing.
Fokom Domgue J; Cunningham SA; Yu RK; Shete S
Ann Epidemiol; 2019 Aug; 36():40-47. PubMed ID: 31320153
[TBL] [Abstract][Full Text] [Related]
10. Picturing Prevalence and Inequalities in Cancer Screening Attendance to Population-Based Programs in Portugal.
Quintal C; Antunes M
Acta Med Port; 2023 Sep; 36(9):577-587. PubMed ID: 37339163
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
[TBL] [Abstract][Full Text] [Related]
12. Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases.
Gök M; Rozendaal L; Berkhof J; Visser O; Meijer CJ; van Kemenade FJ
Br J Cancer; 2011 Feb; 104(4):685-92. PubMed ID: 21266976
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening uptake in women aged between 15 and 64 years in Mozambique.
Brandão M; Tulsidás S; Damasceno A; Silva-Matos C; Carrilho C; Lunet N
Eur J Cancer Prev; 2019 Jul; 28(4):338-343. PubMed ID: 30020115
[TBL] [Abstract][Full Text] [Related]
14. Determinants of Cervical Cancer Screening Uptake in Kurdish Women Living in Western Iran, 2014.
Aminisani N; Fattahpour R; Abedi L; Shamshirgaran SM
Asian Pac J Cancer Prev; 2016; 17(8):3763-7. PubMed ID: 27644614
[TBL] [Abstract][Full Text] [Related]
15. Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010.
Martinez-Huedo MA; Lopez de Andres A; Hernandez-Barrera V; Carrasco-Garrido P; Martinez Hernandez D; Jiménez-Garcia R
Diabetes Metab; 2012 Apr; 38(2):142-8. PubMed ID: 22078638
[TBL] [Abstract][Full Text] [Related]
16. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
[TBL] [Abstract][Full Text] [Related]
17. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
18. Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme.
Macios A; Didkowska J; Wojciechowska U; Komerska K; Glińska P; Kamiński MF; Nowakowski A
Cancer Med; 2021 May; 10(10):3449-3460. PubMed ID: 33934537
[TBL] [Abstract][Full Text] [Related]
19. Never and under cervical cancer screening in Switzerland and Belgium: trends and inequalities.
Jolidon V; De Prez V; Willems B; Bracke P; Cullati S; Burton-Jeangros C
BMC Public Health; 2020 Oct; 20(1):1517. PubMed ID: 33028278
[TBL] [Abstract][Full Text] [Related]
20. Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study.
Tranberg M; Larsen MB; Mikkelsen EM; Svanholm H; Andersen B
BMC Public Health; 2015 Jul; 15():681. PubMed ID: 26194007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
